AMPK-independent autophagy promotes radioresistance of human tumor cells under clinical relevant hypoxia in vitro. Issue 3 (September 2015)
- Record Type:
- Journal Article
- Title:
- AMPK-independent autophagy promotes radioresistance of human tumor cells under clinical relevant hypoxia in vitro. Issue 3 (September 2015)
- Main Title:
- AMPK-independent autophagy promotes radioresistance of human tumor cells under clinical relevant hypoxia in vitro
- Authors:
- Chaachouay, Hassan
Fehrenbacher, Birgit
Toulany, Mahmoud
Schaller, Martin
Multhoff, Gabriele
Rodemann, H. Peter - Abstract:
- <abstract xml:lang="en" abstract-type="author" id="ab005"> <title id="st005">Abstract</title> <sec> <title id="st010">Background and purpose</title> <p id="sp0005">Blocking of the autophagy-signaling has the potential to improve cancer therapy. In the present study, the role of autophagy for radioresistance of human tumor cells was tested under clinically relevant hypoxia (1% O<sub>2</sub>).</p> </sec> <sec> <title id="st015">Materials and methods</title> <p id="sp0010">Non-small cell lung cancer cell lines A549 and H460, head and neck squamous cell carcinoma FaDu, colon carcinoma cell line HCT116 and mouse-embryo-fibroblasts were analyzed under normoxic (21% O<sub>2</sub>) and hypoxic (0.01% and 1% O<sub>2</sub>) conditions with respect to clonogenic cell survival and hypoxia-induced autophagy. Immunofluorescence and electron microscopy were used to monitor the autophagy process and Western blotting of LC3, AMPK, and BNIP3 was applied to analyze autophagy signaling.</p> </sec> <sec> <title id="st020">Results</title> <p id="sp0015">Clinically relevant hypoxia stimulated autophagy in tumor cells as indicated by enhanced LC3-I to LC3-II conversion. Furthermore, hypoxia stimulated autophagy was approved by Immunofluorescence staining and electron-microscopy analysis of autophagosome vacuoles. Preconditioning of tumor cells to moderate-hypoxia increased their radioresistance that was significantly reversed following pretreatment with autophagy inhibitor, chloroquine. Using siRNA<abstract xml:lang="en" abstract-type="author" id="ab005"> <title id="st005">Abstract</title> <sec> <title id="st010">Background and purpose</title> <p id="sp0005">Blocking of the autophagy-signaling has the potential to improve cancer therapy. In the present study, the role of autophagy for radioresistance of human tumor cells was tested under clinically relevant hypoxia (1% O<sub>2</sub>).</p> </sec> <sec> <title id="st015">Materials and methods</title> <p id="sp0010">Non-small cell lung cancer cell lines A549 and H460, head and neck squamous cell carcinoma FaDu, colon carcinoma cell line HCT116 and mouse-embryo-fibroblasts were analyzed under normoxic (21% O<sub>2</sub>) and hypoxic (0.01% and 1% O<sub>2</sub>) conditions with respect to clonogenic cell survival and hypoxia-induced autophagy. Immunofluorescence and electron microscopy were used to monitor the autophagy process and Western blotting of LC3, AMPK, and BNIP3 was applied to analyze autophagy signaling.</p> </sec> <sec> <title id="st020">Results</title> <p id="sp0015">Clinically relevant hypoxia stimulated autophagy in tumor cells as indicated by enhanced LC3-I to LC3-II conversion. Furthermore, hypoxia stimulated autophagy was approved by Immunofluorescence staining and electron-microscopy analysis of autophagosome vacuoles. Preconditioning of tumor cells to moderate-hypoxia increased their radioresistance that was significantly reversed following pretreatment with autophagy inhibitor, chloroquine. Using siRNA against AMPK as well as AMPK deficient cells, autophagy stimulation by 1% O<sub>2</sub> was shown to be AMPK-independent. However, a correlation between the expression of BNIP3 and autophagy-stimulation was observed under this condition.</p> </sec> <sec> <title id="st025">Conclusion</title> <p id="sp0020">Under clinically relevant hypoxia (1% O<sub>2</sub>) the stimulation of autophagy mediates resistance of hypoxic tumor cells to ionizing radiation, which is independent of AMPK signaling.</p> </sec> </abstract> … (more)
- Is Part Of:
- Radiotherapy and oncology. Volume 116:Issue 3(2015:Sep.)
- Journal:
- Radiotherapy and oncology
- Issue:
- Volume 116:Issue 3(2015:Sep.)
- Issue Display:
- Volume 116, Issue 3 (2015)
- Year:
- 2015
- Volume:
- 116
- Issue:
- 3
- Issue Sort Value:
- 2015-0116-0003-0000
- Page Start:
- 409
- Page End:
- 416
- Publication Date:
- 2015-09
- Subjects:
- Oncology -- Periodicals
Radiotherapy -- Periodicals
Tumors -- Periodicals
Medical Oncology -- Periodicals
Neoplasms -- radiotherapy -- Periodicals
Radiotherapy -- Periodicals
Radiothérapie -- Périodiques
Cancérologie -- Périodiques
Tumeurs -- Périodiques
Electronic journals
616.9940642 - Journal URLs:
- http://www.sciencedirect.com/science/journal/01678140 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/01678140 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/01678140 ↗
http://www.estro.org/ ↗
http://www.elsevier.com/journals ↗
http://www.journals.elsevier.com/radiotherapy-and-oncology/ ↗ - DOI:
- 10.1016/j.radonc.2015.08.012 ↗
- Languages:
- English
- ISSNs:
- 0167-8140
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 7240.790000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3956.xml